O Saifi, W G Rule, S C Lester, N N Laack, W Breen, A Rosenthal, S M Ansell, T M Habermann, J Villasboas Bisneto, M Iqbal, M Alhaj Moustafa, H Tun, M Kharfan-Dabaja, J L Peterson, B S Hoppe
PURPOSE/OBJECTIVE(S): Gray zone lymphoma (GZL) is a relatively rare disease predominantly affecting young adults with purportedly poor outcomes with current treatment approaches. The role of radiation therapy (RT) in the management of GZL is not well established. This is the largest study to report on the outcomes of GZL patients treated with and without RT. MATERIALS/METHODS: A retrospective review of 30 patients with GZL treated across 3 institutions from 2009 to 2021 was performed...
October 1, 2023: International Journal of Radiation Oncology, Biology, Physics